Sr Clinical Trial Manager @ (September 2021 - November 2022)
Clinical Process Lead @ (June 2021 - September 2021)
Study Manager @ G1 Therapeutics, Inc. (July 2020 - June 2021)
Clinical Operations Lead @ G1 Therapeutics, Inc. (March 2019 - July 2020)
Director, Clinical Operations @ (July 2018 - March 2019)
Lead CRA @ (May 2016 - July 2018)
Study Manager II @ Social & Scientific Systems (July 2013 - April 2016)
Public Health Research Study Specialist @ (September 2010 - June 2013)
Global Project Specialist and Research Assistant II @ (January 2009 - September 2010)
Global Project Specialist and Research Associate @ (January 2009 - September 2010)
In-House Clinical Research Associate and File Auditor @ (February 2010 - June 2010)
Graduate Research Assistant @ North Carolina Institute for Public Health (May 2008 - January 2009)
Project Assistant @ (September 2006 - August 2007)
Research Assistant I @ (September 2005 - September 2006)
Volunteer @ (January 2003 - April 2005)
Chloe Katz Education
The George Washington University School of Medicine and Health Sciences
MSHS (Clinical Research Administration)
2011-2016
The University of North Carolina at Chapel Hill
MPH (Public Health)
2007-2009
University of California, Santa Cruz
BA (French)
1997-2001
Chloe Katz Skills
Epidemiology
Clinical Research
Analysis
Project Management
Qualitative Research
Data Management
Research
Public Health
Software Documentation
Clinical Trials
Chloe Katz Summary
Chloe Katz, based in Raleigh, NC, US, is currently a Director of Clinical Operations at Peptilogics. Chloe Katz brings experience from previous roles at Invivyd and TG Therapeutics, Inc.. Chloe Katz holds a 2011 - 2016 MSHS in Clinical Research Administration @ The George Washington University School of Medicine and Health Sciences. With a robust skill set that includes Epidemiology, Clinical Research, Analysis, Project Management, Qualitative Research and more. Chloe Katz has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Chloe Katz?
Find contact details for 700 million professionals.